Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy

NCT00123279 is registered in ClinicalTrials.gov with ThromboGenics as lead sponsor.

NCT NCT00123279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy
Lead sponsor
ThromboGenics
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
November 30, 2008
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

eye diseases, vitreomacular traction maculopathy